The U.S. Department of Defense, along with Congressman Tim Holden (D -PA), today announced that SCHOTT North America has been awarded an appropriation of $800,000 in federal funding, which Congressman Holden inserted into the Defense Appropriations Bill. The funding will allow SCHOTT to conduct research into the interaction between biotherapeutic drugs and glass packaging. Currently, such interactions can lead to drug loss due to adsorption, aggregation and precipitation, which diminishes the effectiveness of these drugs.
Read Article
